Kaye Scholer Corporate Partner Diane Holt Frankle advised Sapheon, Inc., a privately-held developer of venous disease treatments, in its acquisition by Covidien plc. Financial terms of the transaction were not disclosed.
Based in Morrisville, NC, Sapheon develops and manufactures the VenaSeal® system, which uses a specially formulated medical adhesive to close the great saphenous vein in patients with varicose veins and chronic venous insufficiency (CVI). According to Brian Verrier, president, Peripheral Vascular, Covidien, “Sapheon will significantly enhance Covidien’s global Peripheral Vascular business by providing additional treatment options for physicians and their patients who suffer from CVI.”
Frankle, who is based in the firm’s Silicon Valley office, represents publicly traded and privately held companies engaged in a wide variety of US and cross-border mergers, acquisitions, strategic alliances and joint ventures, with a particular focus on the technology and life sciences sectors. Simon Inman and Adam Rosenblum of Carle Mackie Power & Ross served as co-counsel on this transaction.
Also of Interest
- SEC Adopts New Rules: Fund Liquidity, Reporting and Disclosure, and “Swing Pricing” December 6, 2016 • Client Alerts
- NLJ Names Yates a 2016 Litigation Trailblazer December 6, 2016 • Recognitions
- Tax Alert: Final Debt Regulations Have Limited Scope of Application November 30, 2016 • Client Alerts
- Best Lawyers Profiles Frankle as “Lawyer of the Year” November 28, 2016 • Media Mentions
- Fallon Appointed to the University at Albany Presidential Search Committee November 22, 2016 • Recognitions
- Fintech Term Sheet Negotiations: Key Issues Beyond Price November 21, 2016 • Articles
- JUVE Handbuch Recommends Frankfurt Office and Lawyers November 14, 2016 • Recognitions
- Using Technology Service Providers Is No Silver Bullet November 7, 2016 • Articles
- Kaye Scholer Advises Bregal, Motion Equity in Morrison Utility Services Sale November 7, 2016 • Client Successes